You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Follicular Lymphoma

Showing 1 - 25 of 6,008
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Patients Undergoing Follicular Lymphoma Clinical Research

Not yet recruiting
  • Follicular Lymphoma
    • San Francisco, California
      Power Life Sciences
    Sep 15, 2023

    Follicular Lymphoma Trial in New York (Mosunetuzumab, Tazemetostat Pill)

    Not yet recruiting
    • Follicular Lymphoma
    • New York, New York
      Weill Cornell Medicine/NewYork-Presbyterian Hospital
    Aug 8, 2023

    Follicular Lymphoma, Refractory Follicular Lymphoma Trial (Tazverik (Tazemetostat))

    Not yet recruiting
    • Follicular Lymphoma
    • Refractory Follicular Lymphoma
    • Tazverik (Tazemetostat)
    • (no location specified)
    Oct 6, 2023

    Follicular Lymphoma Stage II, Follicular Lymphoma Stage III, Follicular Lymphoma Stage IV Trial in Australia (BMS-986369,

    Not yet recruiting
    • Follicular Lymphoma Stage II
    • +2 more
    • Ballarat, Victoria, Australia
    • +4 more
    Mar 15, 2023

    Follicular Lymphoma Trial in Shanghai (lenalidomide, rituximab, parsaclisib)

    Not yet recruiting
    • Follicular Lymphoma
    • Shanghai, Shanghai, China
      Ruijin hospital, school of medicine, Shanghai jiao tong universi
    May 10, 2023

    Follicular Lymphoma, Tumor Trial in Houston (Obinutuzumab, CC-99282)

    Not yet recruiting
    • Follicular Lymphoma
    • Tumor
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 30, 2023

    Lymphoma, Follicular Trial (Mosunetuzumab)

    Not yet recruiting
    • Lymphoma, Follicular
    • (no location specified)
    May 8, 2023

    Follicular Lymphoma, Low Grade Non-Hodgkin's Lymphoma, Adult Trial in Boston (Epcoritamab, Rituximab)

    Not yet recruiting
    • Follicular Lymphoma
    • Low Grade Non-Hodgkin's Lymphoma, Adult
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Mar 13, 2023

    Follicular Lymphoma, Marginal Zone Lymphoma, Indolent Non-hodgkin Lymphoma Trial in Boston (Obinutuzumab, Glofitamab)

    Not yet recruiting
    • Follicular Lymphoma
    • +2 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Mar 13, 2023

    Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage III Follicular Lymphoma, Ann Arbor Stage IV Follicular Lymphoma Trial in

    Recruiting
    • Ann Arbor Stage II Follicular Lymphoma
    • +5 more
    • Fresno, California
    • +2 more
    Jan 24, 2023

    Obinutuzumab-based Therapy for Previously Untreated FL

    Recruiting
    • Follicular Lymphoma
    • Shanghai, Shanghai, China
      Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
    Jun 3, 2023

    Obinutuzumab in Combination With Lenalidomide in Relapsed or

    Recruiting
    • Follicular Lymphoma
      • Tianjin, China
        Institute of Hematology and Blood Diseases Hospital ,Chinese Aca
      Apr 27, 2023

      Living Conditions of Diffuse Large B-Cell Lymphoma or Follicular

      Completed
      • Diffuse Large Cell Diffuse Lymphoma
      • Follicular Lymphoma
      • Questionnaires
      • Collection of clinical data and treatments
      • Dijon, France
        Chu Dijon Bourogne
      Jan 31, 2023

      Follicular Lymphoma, Non-Hodgkin's Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Rituximab, Copanlisib)

      Recruiting
      • Follicular Lymphoma
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 25, 2023

      Follicular Lymphoma (FL) Trial (biological, drug, other)

      Not yet recruiting
      • Follicular Lymphoma (FL)
      • Tisagenlecleucel
      • +4 more
      • (no location specified)
      May 24, 2023

      Relapsed/Refractory Follicular Lymphoma, Marginal Zone Lymphoma (MZL) Trial in Chiang Mai (Odronextamab, Lenalidomide,

      Recruiting
      • Relapsed/Refractory Follicular Lymphoma
      • Marginal Zone Lymphoma (MZL)
      • Chiang Mai, Thailand
        Chiang Mai University
      Nov 20, 2023

      Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann

      Active, not recruiting
      • Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma
      • +11 more
      • Washington, District of Columbia
      • +6 more
      Feb 2, 2023

      DLBCL - Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in Xiamen (Lenalidomide combined with G-CHOP (LO CHOP))

      Recruiting
      • DLBCL - Diffuse Large B Cell Lymphoma
      • Follicular Lymphoma
      • Lenalidomide combined with G-CHOP (LO CHOP)
      • Xiamen, Fujian, China
        Bing Xu
      Nov 28, 2023

      Follicular Lymphoma Trial in Australia (Opdivo)

      Active, not recruiting
      • Follicular Lymphoma
      • Ballarat, Victoria, Australia
      • +4 more
      Jan 30, 2023

      Follicular Lymphoma Trial (Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine phosphate)

      Not yet recruiting
      • Follicular Lymphoma
      • Axicabtagene Ciloleucel
      • +5 more
      • (no location specified)
      Sep 21, 2023

      Follicular Lymphoma (FL) Trial in Noblesville (Odronextamab, Rituximab, Cyclophosphamide)

      Recruiting
      • Follicular Lymphoma (FL)
      • Noblesville, Indiana
        Investigative Clinical Research of Indiana
      Oct 18, 2023

      Relapsed Follicular Lymphoma, Refractory Follicular Lymphoma Trial in Boston (TAZEMETOSTAT, Zandelisib)

      Not yet recruiting
      • Relapsed Follicular Lymphoma
      • Refractory Follicular Lymphoma
      • Boston, Massachusetts
      • +1 more
      Oct 28, 2022

      Follicular Lymphoma (FL) Trial in Westbury (Odronextamab, Rituximab, Cyclophosphamide)

      Recruiting
      • Follicular Lymphoma (FL)
      • Westbury, New York
        Clinical Research Alliance Inc
      Oct 13, 2023

      Lymphoma, Follicular, Follicular Lymphoma Trial in Saint Louis (Mosunetuzumab, Polatuzumab vedotin)

      Recruiting
      • Lymphoma, Follicular
      • Follicular Lymphoma
      • Saint Louis, Missouri
        Washington University School of Medicine
      Nov 14, 2022

      Follicular Lymphoma, Mantle Cell Lymphoma Trial in Rouen (Determination of COVID-19 vacciantion efficacy)

      Completed
      • Follicular Lymphoma
      • Mantle Cell Lymphoma
      • Determination of COVID-19 vacciantion efficacy
      • Rouen, France
        Centre Henri Becquerel
      Dec 22, 2022